Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ryusei Saitou"'
Autor:
Takahiro Sawahara, Ryo Matsumoto, Yuki Nakahira, Hidetomo Usui, Noriyuki Kataoka, Ryusei Saitou, Takanori Wakita, Takayoshi Yokoya, Aichi Yamashita, Yosuke Goto, Yoshihiko Takano, Akira Miura, Yoshikazu Mizuguchi
Publikováno v:
ACS Omega. 8:11288-11292
Autor:
Satoru Watanabe, Hidehiko Nakano, Takeyuki Makimoto, Shinichi Ishihara, Masatomo Mori, Ichirou Naruse, Yoshikazu Takei, Satoshi Tsuchiya, Taisuke Nomoto, Ryusei Saitou
Publikováno v:
The KITAKANTO Medical Journal. 45:185-190
Autor:
Mai Tomizawa, Osamu Kawashima, Yoshio Tomizawa, Ryusei Saitou, Akihiro Yoshii, Masanobu Yamada, Reiko Yoshino, Takeshi Hisada, Satoru Watanabe, Kousuke Takei
Publikováno v:
Annals of Oncology. 26:vii98
Autor:
Masanobu Yamada, Hisao Imai, Yoshio Tomizawa, Mai Tomizawa, Satoru Watanabe, Ryusei Saitou, Reiko Yoshino, Kousuke Takei, Akihiro Yoshii
Publikováno v:
Annals of Oncology. 25:v96
Background: The effects of first-line chemotherapy on overall survival(OS) might be confounded by subsequent therapies in patients with non-small cell lung cancer(NSCLC) harboring EGFR mutation. We retrospectively examined whether progression-free su
Autor:
Tomohito Kuwako, Akihiro Yoshii, Ryusei Saitou, Reiko Yoshino, Satoru Watanabe, Kousuke Takei, Yoshio Tomizawa
Publikováno v:
Annals of Oncology. 24:ix96
Background: The efficacy of re-administration of gefitinib was reported in the cases of response to initial treatment with gefitinib. We retrospectively evaluated the efficacy and safety of treatment with EGFR TK-Is re-challenge in patients with adva
Autor:
Reiko Yoshino, Yoshio Tomizawa, Yosuke Miura, Ryusei Saitou, M. Nishioka, Akihiro Yoshii, Masatomo Mori, Satoru Watanabe
Publikováno v:
Annals of Oncology. 23:xi135
Background The addition of bevacizumab to platinum-based regimens improved the response rate and the progression-free survival (PFS) with advanced non-squamous NSCLCs. We retrospectively evaluated the efficacy and safety of treatment with bevacizumab